Skip to contentMILDER DONALD B — Inari Medical, Inc. insider: 183 transactions · InsiderLensMILDER DONALD B
- Former 10% Holder at Alexza Pharmaceuticals Inc. · on record since Mar 14, 2006
- 10% owner at Alexza Pharmaceuticals Inc. · on record since Mar 8, 2006
- 10% owner at NOVACEA INC · on record since May 15, 2006
- 10% owner at HELICOS BIOSCIENCES CORP · on record since May 24, 2007
- Former 10% Owner at INSULET CORP · on record since May 17, 2007
- 10% owner at INSULET CORP · on record since May 14, 2007
- Director at Flexion Therapeutics Inc · on record since Sep 12, 2014
- 10% owner at Flexion Therapeutics Inc · on record since Sep 12, 2014
- 10% owner at INTROGEN THERAPEUTICS INC · on record since Sep 12, 2014
- 10% owner at GENOMIC HEALTH INC · on record since Sep 28, 2005
- 10% owner at Vivani Medical, Inc. · on record since Nov 18, 2014
- 10% owner at GLAUKOS Corp · on record since Jun 30, 2015
- Director at INTRALASE CORP · on record since Oct 6, 2004
- 10% owner at INTRALASE CORP · on record since Oct 6, 2004
- 10% owner at PHASERX, INC. · on record since May 24, 2016
- former 10% holder at GLAUKOS Corp · on record since Jun 2, 2016
- Director at Inari Medical, Inc. · on record since May 27, 2020
- 10% owner at Inari Medical, Inc. · on record since May 27, 2020
- Former Director at INTRALASE CORP · on record since Aug 2, 2005
Insider trading activity of MILDER DONALD B
- Transactions on record
- 183
- since Oct 13, 2004
- Open-market buys
- 6
- $8.2M
- Open-market sells
- 83
- $15.9M
- Companies traded
- 6
- last filing Feb 19, 2025
Figures computed from official regulatory filings — methodology.
Companies where MILDER DONALD B has traded
Track record of MILDER DONALD B
Statistical track record
Free- Open-market buys
- 7
- Last buy
- Nov 8, 2023
Win rates and median returns are available with a free account (5 insiders/month).
Create a free account→Transaction history of MILDER DONALD B
Co-insiders of MILDER DONALD B
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
Warden Charles MAlexza Pharmaceuticals Inc. +6
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Feb 19, 2025 | Other | -2,831,714 | — | — | SEC |
| Feb 19, 2025 | Other | -259,126 | — | — | SEC |
| May 31, 2024 | Buy | 100 | 52.23 USD | $5.2K | SEC |
| May 31, 2024 | Buy | 54,000 | 53.44 USD | $2.9M | SEC |
| May 31, 2024 | Buy | 2,000 | 53.54 USD | $107.1K | SEC |
| Apr 26, 2024 | Award | 4,126 | 42.41 USD | $175K | SEC |
| Dec 15, 2023 | Gift | -100,000 | 0.00 USD | $0 | SEC |
| Dec 15, 2023 | Gift | -100,000 | 0.00 USD | $0 | SEC |
| May 30, 2023 | ExerciseD | -2,982 | 0.00 USD | $0 | SEC |
| May 30, 2023 | Exercise | 2,982 | 0.00 USD | $0 | SEC |
| May 19, 2023 | Award | 2,412 | 0.00 USD | $0 | SEC |
| Feb 13, 2023 | Gift | -210,000 | 0.00 USD | $0 | SEC |
| Nov 16, 2022 | Sell | -7,000 | 80.13 USD | $560.9K | SEC |
| Oct 19, 2022 | Sell | -7,000 | 80.07 USD | $560.5K | SEC |
| Sep 16, 2022 | Sell | -7,000 | 80.25 USD | $561.8K | SEC |
| Aug 17, 2022 | Sell | -5,500 | 80.56 USD | $443.1K | SEC |
| Aug 17, 2022 | Sell | -300 | 82.40 USD | $24.7K | SEC |
| Aug 17, 2022 | Sell | -1,200 | 81.41 USD | $97.7K | SEC |
| Aug 17, 2022 | Gift | -210,000 | 0.00 USD | $0 | SEC |
| Aug 4, 2022 | Gift | -210,000 | 0.00 USD | $0 | SEC |
| Aug 4, 2022 | Sell | -6,204 | 80.36 USD | $498.6K | SEC |
| Aug 4, 2022 | Sell | -6,205 | 80.35 USD | $498.6K | SEC |
| Aug 4, 2022 | Sell | -6,138 | 80.33 USD | $493.1K | SEC |
| Aug 4, 2022 | Sell | -795 | 81.14 USD | $64.5K | SEC |
| Aug 4, 2022 | Sell | -796 | 81.16 USD | $64.6K | SEC |